145 related articles for article (PubMed ID: 1829967)
1. C4b-binding protein exacerbates the host response to Escherichia coli.
Taylor F; Chang A; Ferrell G; Mather T; Catlett R; Blick K; Esmon CT
Blood; 1991 Jul; 78(2):357-63. PubMed ID: 1829967
[TBL] [Abstract][Full Text] [Related]
2. Role of free protein S and C4b binding protein in regulating the coagulant response to Escherichia coli.
Taylor FB; Dahlback B; Chang AC; Lockhart MS; Hatanaka K; Peer G; Esmon CT
Blood; 1995 Oct; 86(7):2642-52. PubMed ID: 7670107
[TBL] [Abstract][Full Text] [Related]
3. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor.
Taylor FB
Prog Clin Biol Res; 1994; 388():175-94. PubMed ID: 7831358
[TBL] [Abstract][Full Text] [Related]
4. Protein S enhances C4b binding protein interaction with neutrophils.
Furmaniak-Kazmierczak E; Hu CY; Esmon CT
Blood; 1993 Jan; 81(2):405-11. PubMed ID: 8422460
[TBL] [Abstract][Full Text] [Related]
5. 7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli.
Taylor FB; Coller BS; Chang AC; Peer G; Jordan R; Engellener W; Esmon CT
Blood; 1997 Jun; 89(11):4078-84. PubMed ID: 9166848
[TBL] [Abstract][Full Text] [Related]
6. Protein S, C4b binding protein, and the hypercoagulable state.
Taylor FB
J Lab Clin Med; 1992 Jun; 119(6):596-7. PubMed ID: 1534344
[No Abstract] [Full Text] [Related]
7. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis.
Taylor FB; Stearns-Kurosawa DJ; Kurosawa S; Ferrell G; Chang AC; Laszik Z; Kosanke S; Peer G; Esmon CT
Blood; 2000 Mar; 95(5):1680-6. PubMed ID: 10688824
[TBL] [Abstract][Full Text] [Related]
8. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli.
Taylor FB; Chang AC; Peer G; Li A; Ezban M; Hedner U
Blood; 1998 Mar; 91(5):1609-15. PubMed ID: 9473226
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.
Creasey AA; Stevens P; Kenney J; Allison AC; Warren K; Catlett R; Hinshaw L; Taylor FB
Circ Shock; 1991 Feb; 33(2):84-91. PubMed ID: 2049816
[TBL] [Abstract][Full Text] [Related]
10. Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern.
de Boer JP; Creasey AA; Chang A; Roem D; Eerenberg AJ; Hack CE; Taylor FB
Infect Immun; 1993 Oct; 61(10):4293-301. PubMed ID: 8406818
[TBL] [Abstract][Full Text] [Related]
11. Rapid recovery of acquired purpura fulminans in a patient with familial C4bBP deficiency.
Lemesle FG; Gris JC; Schwed JF; Arich C
Intensive Care Med; 1993; 19(2):115-6. PubMed ID: 8486865
[TBL] [Abstract][Full Text] [Related]
12. Retrospective description and experimental reconstitution of three different responses of the baboon to lethal E. coli.
Taylor FB; Kosanke S; Randolph M; Emerson T; Hinshaw LB; White GL; Chang AC; Peer G; Blick K
Circ Shock; 1994 Feb; 42(2):92-103. PubMed ID: 8013066
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.
Minnema MC; Chang AC; Jansen PM; Lubbers YT; Pratt BM; Whittaker BG; Taylor FB; Hack CE; Friedman B
Blood; 2000 Feb; 95(4):1117-23. PubMed ID: 10666179
[TBL] [Abstract][Full Text] [Related]
14. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.
Taylor FB
Crit Care Med; 2001 Jul; 29(7 Suppl):S78-89. PubMed ID: 11445739
[TBL] [Abstract][Full Text] [Related]
15. Recurrent venous thrombosis during warfarin treatment related to acquired protein S deficiency.
Odegaard OR; Lindahl AK; Try K; Kvalheim G; Sørbø JH
Thromb Res; 1992 Jun; 66(6):729-34. PubMed ID: 1519231
[TBL] [Abstract][Full Text] [Related]
16. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.
Jansen PM; van der Pouw Kraan TC; de Jong IW; van Mierlo G; Wijdenes J; Chang AA; Aarden LA; Taylor FB; Hack CE
Blood; 1996 Jun; 87(12):5144-51. PubMed ID: 8652827
[TBL] [Abstract][Full Text] [Related]
17. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
Dahlbäck B
Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the capacity of rhTNF-alpha and Escherichia coli to induce procoagulant activity by baboon mononuclear cells in vivo and in vitro.
Li A; Chang AC; Peer GT; Hinshaw LB; Taylor FB
Shock; 1996 Apr; 5(4):274-9. PubMed ID: 8721387
[TBL] [Abstract][Full Text] [Related]
19. Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes.
Ceriello A; Giugliano D; Quatraro A; Marchi E; Barbanti M; Lefebvre P
Diabetes; 1990 Apr; 39(4):447-9. PubMed ID: 2138576
[TBL] [Abstract][Full Text] [Related]
20. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.
Taylor FB; Chang AC; Peer GT; Mather T; Blick K; Catlett R; Lockhart MS; Esmon CT
Blood; 1991 Jul; 78(2):364-8. PubMed ID: 2070073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
